Hidden Agendas? Teva v Pfizer
In May of 2011, the Supreme Court of Canada granted Teva Canada leave to appeal the Federal Court of Appeal’s decision, Teva v Pfizer, 2010 FCA 242. At issue is...
Category: Patents
Amazon’s “One-Click” Patent Granted in Canada: A Case Comment on the Federal Court of Appeal Decision
The patentability of business methods has been a major source of controversy in Canadian patent law. While the Federal Court of Appeal (“FCA”) had the opportunity to clarify the patentability...
A “One-Click” Patent: Canada (Finally) Opens-Up Possibility for Business Method Patents in Amazon.com, Inc v Attorney General
In a previous post on the US Supreme Court decision, Bilski et al v Kappos, No.08-964 545 F. 3d 943 [Bilski], I discussed how SCOTUS alluded to the possibility that “business methods”...
U.S. Supreme Court in Bilski et al. v. Kappos tap floodgates for “business methods patents”
On June 28, 2010, the US Supreme Court released its reasons in Bilski et al. v. Kappos, No.08-964 545 F. 3d 943 (PDF link) (“Bilski”). The case was widely followed,...
